Sofinnova News
Sofinnova Crossover & Sofinnova Industrial Biotech
Sofinnova Partners’ Antoine Papiernik spoke with In Vivo magazine’s William Looney on European #venturecapital, #investment strategy, and more. https://bit.ly/2GIP9rZ @INVIVOnow @BillInVivo
Sofinnova Partners’ Antoine Papiernik spoke with In Vivo magazine’s William Looney on European #venturecapital, #investment strategy, and more. https://bit.ly/2GIP9rZ @INVIVOnow @BillInVivo
Related Strategy
CrossoverRelated Deal lead
Antoine Papiernik
Related News
In Memory of Denis Lucquin
Biotalys achieves first milestone in bioinsecticide partnership with Syngenta
Abivax announces full year 2025 financial results and provides business updates
Sensorion reports six-month update from the Audiogene Phase 1/2 Trial of SENS-501 and advances GJB2-GT (SENS-601) toward first-in-human clinical development
May Health raises $11.7M to advance its novel technology to treat PCOS-related infertility